International Cannabis Weekly: 159

• Australia records record monthly medical cannabis patient growth in July.
• Online sentiment predominantly positive ahead of New Zealand cannabis referendum.
• Portugal establishes a regulatory framework for the nation’s hemp industry.
• Thai Cabinet approves draft law to expand the nation’s cannabis industry.

• Europe’s largest cannabis registry, Project Twenty21, goes live.
• Switzerland refunds €42.5 million in taxes to low-THC cannabis farmers and producers.
• Cyprus passes bill to regulate the prescription and distribution of medical cannabis.
• Tilray recalls weak-THC batches of medical cannabis oils supplied to Germany.
• European-owned medical cannabis is now available in German pharmacies.

Get your copy of Impact: Disrupting Drinks, now.

ACCESS EXCLUSIVE INSIGHTS

• Bruce Linton aims to ‘revitalise hemp’ with The Collective Growth Corporation.
• FDA approves Epidiolex for the treatment of tuberous sclerosis complex seizures.
• Rhode Island governor supports legalising cannabis to raise state revenue.
• Illinois adult-use cannabis sales reach over US$300 million since January 2020.
• Michigan allows stand-alone adult-use cannabis licences one year early.

• Canadian cannabis companies receive a deadline extension for annual regulatory fees.
• FSD Pharma liquidates cannabis subsidiary, FV Pharma, to focus on COVID-19 vaccine.
• Canada’s legal cannabis industry contributes CA$4.7 billion to the economy.
• MYM Nutraceuticals acquires licensed cultivator Highland Grow.
• Cronos Group reports an operating loss of US$31.3 million in Q2 2020.

• Brazilian patient authorisations for medical cannabis imports to reach 18,650.
• Dominica considers legislation to decriminalise cannabis.
• Bermuda drafts proposal to develop an adult-use cannabis regime.
• Together signs a deal to market and distribute medical cannabis in Brazil.

• A medical spray created by MGC Pharmaceuticals may help treat COVID-19 symptoms.
• Village Farms International has announced it will acquire a stake in Altum International.
• Cannabis criminalisation is costing Australia AU$1.1 billion annually.
• Myanmar plans to legalise hemp production for commercial products.
• Little Green Pharma plans to support cannabis facilities with Western Australia grant.

• South African Cabinet approves a bill to regulate the private use of cannabis.
• Israel’s Health Ministry presents reforms to reduce medical cannabis price by 50%.
• Aphria enters an agreement with Canndoc to supply the Israeli market.

The largest ever month-on-month increase of cannabis patient authorisations was recorded in Australia for the month of July, as patient figures were shown to surge in newly released data from Australia’s Therapeutic Goods Administration.

Read the full analysis from Prohibition Partners, here.